Shine a light on potential new treatments for RSV
Now recruiting: A clinical trial for people with Respiratory Syncytial Virus (RSV) infection. Participants in this clinical trial will receive care from a team of specialists and contribute to research on RSV infection that may help protect more people from severe illness caused by this virus.
To qualify, you must:
- Be 65 years or older
Qualified participants will receive:
- Study-related medication at no cost
- Study-related medical exams at no cost
- Compensation for time and travel
No insurance is needed to participate.
Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.
The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.
Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.